Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study
- PMID: 40280481
- DOI: 10.1016/j.diabet.2025.101647
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study
Abstract
Background: Musculoskeletal disorders (MSDs) are common, but overlooked, complications of type 1 diabetes mellitus (T1DM). This study aims to describe MSD phenotypes (clinical, lifestyle, socio-economic) in adults with T1DM.
Methods: We analyzed adult participants in the SFDT1 cohort study. We assessed the following MSDs: stress fractures, non-traumatic upper-limb disorders, and entrapment syndromes. We performed a cross-sectional analysis of the association between MSDs and various factors. After applying multiple imputations for missing data, we computed logistic regression models with progressive adjustments on confounding factors.
Results: Of 1832 participants (53 % men, median age 38 (IQR 22) years), 34 % reported at least one personal history of MSD: 8 % for stress fractures, 24 % for upper-limb disorders and 15 % for entrapment syndromes. A higher prevalence of MSDs was found in women, with aging and with diabetes duration. In a fully adjusted model, we observed a positive association between current smoking (OR [95 %CI] = 1.50 [1.14;1.97]), non-excessive alcohol consumption (1.45 [1.14;1.85]), neuropathy (1.70 [1.35;2.15]), retinopathy (1.30 [1.02;1.65]), use of automated insulin delivery systems (1.53 [1.06;2.21]) and MSDs. MSDs were associated with reduced global quality of life (0.97 [0.95;0.98]). MSDs were not associated with HbA1c, social vulnerability or physical activity.
Conclusion: We have shown that MSDs are found in 1 in 3 people with T1DM. They are associated with several lifestyle factors, diabetes complications and the use of automated insulin delivery systems. MSDs should be considered in the T1DM assessment to optimize quality of life.
Keywords: Diabetes complications; Diabetic neuropathy; Entrapment syndromes; Fractures; Musculoskeletal disorders; Type 1 diabetes; Upper-limb disorders.
Copyright © 2025 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest JPR is an advisory panel member for Sanofi Aventis MSD, Eli Lilly, Novo Nordisk, AstraZeneca, Abbott, Dexcom, Alphadiab and Medtronic, and has received research funding from Abbott, Air Liquide Santé International, Sanofi-Aventis and Novo Nordisk. SP declares no conflict of interest directly related to this article. Outside the submitted work she received speaker and/or consulting honoraria from Abbott, Air Liquide, Asdia, Dexcom, Insulet, Isis Diabetes, Lifescan, Lilly, Medtronic, Novo Nordisk, Orkyn, Roche Diabetes Care, Sanofi, VitalAire. JBJ has received consulting fees from Sanofi and lecture fees from Eli Lilly, Novo Nordisk, and Sanofi. GF has provided advisory/speaking services for and/or has received research grants and/or speaker honoraria from MSD, MSDAvenir, Eli Lilly, Roche Diabetes Care, AstraZeneca, Danone Research, Diabeloop, Bristol Myers Squibb, L’Oréal R&D, Abbvie Pharmaceutical, Pfizer, Vitalaire and Akuity Care.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical